« Back

Mary J. Ninan, MD
Assistant Professor, Division of Hematology/Oncology

Mary J. Ninan, MD

Mary J. Ninan, MD
Assistant Professor, Division of Hematology/Oncology
Department of Internal Medicine

UTMB Hematology/Oncology - Dickinson
2401 FM 646 Ste C
Dickinson, TX 77539
Phone: 281.534.8380
Fax: 281.534.8399


Dr. Mary J Ninan is an Assistant Professor in the Division of Hematology and Oncology. She received her medical degree from Trichur Medical College, India in 1999. She performed her internal medicine residency at Atlanta Medical Center, GA and then subsequently completed her Hematology and Oncology fellowship at the University of Minnesota.

Dr.Ninan joined the faculty at the UTMB in 2010. She is board certified in Internal Medicine, Hematology and Medical Oncology and has a special interest the management of benign and hematologic malignancies, lymphoma and breast cancer. Her research interests include novel therapies in leukemia and lymphoma.

Recent Media/Articles

  • Kodali D, Rawal A, Ninan MJ, Patel MR, Mesa H, Knapp D, Schnitzer B, Kratzke RA, Gupta P. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues. Arch Pathol Lab Med. 2011 Mar;135(3):365-71. PubMed PMID: 21366462.
  • Ninan MJ, Wadhwa PD, Gupta P. Prognostication of diffuse large B-cell lymphoma in the rituximab era. Leuk Lymphoma. 2011 Mar;52(3):360-73. Epub 2011 Jan 28. PubMed PMID: 21275631.
  • Ninan MJ, Datta YH. Post-transplant lymphoproliferative disorder presenting as multiple myeloma. Am J Hematol. 2010 Aug;85(8):635-7. PubMed PMID: 20578201.
  • Ninan MJ, Morrison VA. Therapeutic approaches to non-Hodgkin's lymphoma in the elderly patient. Expert Rev Hematol. 2009 Apr;2(2):173-82. PubMed PMID: 21083450
  • Ninan MJ, Flowers CR, Roback JD, Arellano ML, Waller EK. Posttransplant thrombopoiesis predicts survival in patients undergoing autologous ematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant. 2007 Aug;13(8):895-904. Epub 2007 May 23. PubMed PMID: 17640593.

»Pub Med Search
»Curriculum Vitae

The department of internal medicine is developing evidence based clinical protocols which will be available in EPIC (as order sets) for use when admitting patients with these diagnoses. Their AIM is to standardize care and decrease length of stay and readmission rates.

Currently available protocols are:
  • CAP - Community Acquired Pneumonia Order set
  • Congestive Heart Failure (CHF)
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Diabetic Ketoacidosis Adult, ICU
  • General Medicine Admission
  • Immunodeficiency Flow Panel
  • MICU/CCU Admission Order Set
  • Oral Analgesic Medications
  • Parenteral Opioids
  • Sepsis, Adult ICU
  • 111 - Stroke Alert
  • 112 - Stroke Activation
  • 300086 - Stroke Floor Admission
  • 3000000001 -  Stroke Critical care without tPA
  • 300088 Stroke - Transfer from Critical care to floor
  • 3004002 - Stroke Discharge

All protocols can be found in the EPIC order set section.

» For more information

Meaning Use logo

The department of Internal Medicine has a large role in the Meaningful Use Initiative. Our participation is key for the success of the initiative. Please visit the meaningful use website for important communication and updates from the Meaningful Use Initiative.

Site Managed by UTMB Information Design Services.